Recall Register

Drug recall: Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research…

Class II FDA enforcement event 63691. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

GlaxoSmithKline, LLC. started this drug recall on 8 Oct 2012. The firm address in the FDA record is in Zebulon, NC. FDA put the recall in Class II. FDA event 63691 has 1 product record. The first FDA enforcement report date is 5 Dec 2012. The record gives the status Terminated, with the termination date 11 Sep 2014. 54 of the 209 drug events that started in 2012 have more product records. The median drug event of 2012 has 1 product record. The openFDA file has 209 drug events that started in 2012 and 22 that started in 2011.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide

Recalling firm

GlaxoSmithKline, LLC., Zebulon, NC.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 63691: product records
Recall numberProductQuantityClassStatusReport date
D-068-2013Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-061,319 vialsClass IITerminated5 Dec 2012

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2012
209
Share of these events in Class II
56%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
13

Other events of the firm

Other FDA enforcement events of GlaxoSmithKline, LLC.
InitiatedProduct (first record)TypeClassRecords
17 May 2024Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tableDrugClass III1
12 Dec 2023ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1 inhaler contains 30 doses (60 blisters tDrugClass III1
13 May 2022Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NC 27709, NDC 497DrugClass III1
16 May 2017Ventolin HFA (albuterol sulfate) Inhalation, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhalers, Rx onDrugClass II1
22 Mar 2017Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhalerDrugClass II1
18 Jul 2016Bactroban Cream, (Mupirocin Calcium Cream 2%), 15 gram tube, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709,DrugClass II4
3 Dec 2015Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, –200 Metered Inhalations, Rx Only, For Oral IDrugClass II1
13 Aug 2015Bactroban (mupirocin calcium) Nasal Ointment, 2% 1g tube, Rx only, Manufactured by Glaxo Operations UK Ltd, Harmire RoadDrugClass II4
6 Nov 2013Imitrex STATdose System, Imitrex (sumatriptan succinate) Injection, 2 prefilled 0.5 mL syringe cartridges each containinDrugClass II2
17 Oct 2013Biotene Moisturizing Mouth Spray, with xylitol, For dry mouth symptom relief, 44.3ml/1.5 FL. OZ., Sugar Free Sweetened wDeviceClass II1

GlaxoSmithKline, LLC.: all 13 events

Official channels

Cite this page

Recall Register. FDA enforcement event 63691. https://recallregister.com/fda/ii/63691/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide
What quantity of product is in FDA event 63691?
The FDA record gives this quantity: 1,319 vials
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2012 have the same class?
56% of the 209 drug events that started in 2012 are in Class II.